市場調査レポート
商品コード
1447719
採血デバイス市場の評価:製品タイプ・用途・手法・エンドユーザー・地域別の機会および予測 (2017~2031年)Blood Collection Devices Market Assessment, By Product Type, By Application, By Method,, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。 詳細はお問い合わせください。
採血デバイス市場の評価:製品タイプ・用途・手法・エンドユーザー・地域別の機会および予測 (2017~2031年) |
出版日: 2024年03月11日
発行: Market Xcel - Markets and Data
ページ情報: 英文 230 Pages
納期: 3~5営業日
|
世界の採血デバイスの市場規模は、2023年の78億1,000万米ドルから、2024年から2031年の予測期間中は6.53%のCAGRで推移し、2031年には129億5,000万米ドルの規模に成長すると予測されています。
採血デバイスは、研究や患者の治療・診断の分野で幅広い役割を果たしています。市場の拡大は、血液疾患、輸血、献血の急増によって支えられています。世界保健機関 (WHO) によると、世界では約1億1,854万件の献血が行われており、そのうち40%は世界人口の16%を擁する高所得国から集められたものです。
世界のさまざまな地域での医療施設や病院数の増加や、先進的な採血デバイスの利便性と安全性に対する意識の高まりなども市場の成長を牽引しています。さらに、先進医療技術の利用促進に向けた政府によるイニシアチブの拡大も採血デバイスの需要をさらに押し上げています。
在宅血液検査が製品需要を押し上げる
在宅血液検査の人気の高まりは、このサービスが提供する利便性に起因しています。さまざまな診断検査企業が在宅での採血の予約を受けています。これらの企業は、患者の家に採血技師を派遣し、採血を行い、ラボに送付します。混雑した場所や長い待ち時間を避けることができ、患者は自宅での採血をより好ましく考えています。
また、家庭用の採血デバイスが、そのコスト効率と利便性から、慢性疾患に苦しむ患者の間で人気を得ています。慢性疾患の患者を対象としたオンライン調査によると、参加者1,311人のうち71%が慢性疾患のモニタリングに家庭用の採血デバイスの使用を好んでおり、31%が採血の予約による負担を表明しています。
慢性疾患と生活習慣病の有病率の増加が市場拡大を支える
さまざまな生活習慣病の有病率の増加は、運動不足、喫煙、不健康な食生活など、不健全な生活習慣に長期間さらされることによって起こります。これらの行動は、糖尿病、脳卒中、メタボリックシンドロームなどの発症につながります。このような慢性疾患は、多くの場合、長年の身体障害、自立性の喪失、死亡につながり、経済的にも大きな負担となります。WHOによると、2030年までに、慢性疾患による死亡の割合は70%に上昇すると推定されています。これらの疾患は頻繁な血液検査を必要とするため、さまざまな採血デバイスの需要が高まっています。血液検査はこのような疾患の早期診断や長期管理に不可欠です。
当レポートでは、世界の採血デバイスの市場を調査し、市場の定義と概要、市場規模の推移・予測、各種区分・地域別の詳細分析、産業構造、市場成長への影響因子の分析、ケーススタディ、競合情勢、主要企業のプロファイルなどをまとめています。
Global blood collection devices market is projected to witness a CAGR of 6.53% during the forecast period 2024-2031F, growing from USD 7.81 billion in 2023 to USD 12.95 billion in 2031F. The market has witnessed significant growth over the historical period and is expected to generate similar results over the forecast period.
Blood collection devices play a wide range of roles in the fields of research and patient treatment and diagnosis. The market expansion is supported by surging cases of blood disorders, transfusions, and donations. According to the World Health Organization (WHO), approximately 118.54 million blood donations happened globally, out of these 40% were collected from high-income countries, housing 16% of the global population.
The increase in number of healthcare facilities and hospitals in various regions across the globe coupled with rising awareness about the convenience and safety offered by advanced blood collection devices, driving the growth of the market. Additionally, rising initiatives by various governments to promote the utilization of advanced healthcare technologies is further boosting the demand for blood collection devices.
Due to the growing prevalence of various lifestyle-related disorders, especially in developing countries, the requirement for frequent health check-ups is rapidly increasing. Furthermore, health check-ups are becoming increasingly popular in workplaces to ensure employee well-being. These factors are boosting the requirement for blood tests as they are essential for the identification of various diseases and disorders.
Increasing cases related to chronic health conditions including high cholesterol and diabetes are boosting the demand for blood tests, in turn propelling the requirement for blood collection devices. According to the Centre for Disease Control and Prevention, approximately 86 million adults in the United States aged 20 or older have total cholesterol levels above 200 mg/dL and about 25 million adults have total cholesterol levels above 240 mg/dL.
At-Home Blood Tests Boost Product Demand
The growing popularity of at-home blood testing can be attributed to the convenience offered by the service. Various diagnostic testing companies are known to offer in-home appointments for the collection of blood samples. They send mobile phlebotomists to the patient's home to have the blood drawn and send the sample off to the laboratory. Patients consider at home blood collection more suitable as compared to venous phlebotomy on location. The crowded locations and long waiting periods can be avoided with the help of at-home blood tests.
Additionally, at-home blood sampling devices are becoming popular among patients suffering from chronic health conditions due to the cost efficiency and convenience offered by the devices. According to an online survey of patients suffering from chronic health conditions, of 1311 participants, 71% prefer using at-home blood-sampling devices for monitoring their chronic diseases and 31% expressed the burden caused due to phlebotomy appointments.
Increasing Prevalence of Chronic and Lifestyle Related Diseases Support Market Expansion
The growing prevalence of different lifestyle related diseases can be attributed to prolonged exposure to various modifiable lifestyle behaviors, including physical inactivity, smoking, and unhealthy diets. These behaviors result in the development of diabetes, stroke, and metabolic syndrome, among others. Such chronic diseases can often result in years of disability, loss of independence, death, and can pose significant economic burdens. According to the World Health Organization (WHO), by 2030, the proportion of deaths caused by chronic diseases is estimated to rise to 70%. These diseases require frequent blood testing, propelling the demand for different blood collection devices. Blood tests are essential for early diagnosis of such conditions as well as for the long-term management of the disease.
North America Expected to Account for Significant Market Share
North America is expected to account for a significant share of the market over the forecast period. The growth can be attributed to the high blood donation activities in the region due to growing awareness about the benefits and advantages of blood donations. According to the Red Cross, approximately 13.6 million units of red blood cells and whole blood are collected in the United States in a year. They estimated that approximately 6.8 million individuals in the United States donate blood in a year. The growing prevalence of various chronic disorders including diabetes in the region is propelling the requirement for blood tests, boosting the demand for blood collection devices.
As per the Diabetes Research Institution, approximately 11.3% of the population of the United States or 37.3 million people have diabetes and about 8.6 million individuals have diabetes that is yet to be diagnosed. The surge in geriatric population, rapid expansion of the healthcare sector, technological advancements in blood collection devices, and strong presence of various key market players are further supporting the market expansion in North America.
Blood Collection Tubes Expected to Hold Significant Market Share
Blood collection tubes held a significant share of the market over the historical period and are expected to do so over the forecast period as well. Different types of blood collection tubes are used for collecting samples for conducting various types of tests. For instance, blood collection tubes used for collecting whole blood often are coated with anticoagulants to inhibit coagulation. Similarly, for routine hematology tests, blood collection tubes that contain EDTA, a chelating anticoagulant are required as EDTA aids in preserving the morphology of the cellular blood elements. Likewise, blood collection tubes that contain heparin aid in stabilizing red blood cell membranes that are used for conducting red cell fragility tests and various specialized chemistry tests.
Clinical Laboratories Account for Significant Market Share
The increasing requirement for blood collection devices by clinical laboratories can be attributed to the growing prevalence of various diseases such as coronary heart diseases, HIV/AIDS, cancer, diabetes, and others. These diseases and disorders require blood tests to receive a diagnosis. According to the American Cancer Society, in 2023 approximately 609,820 cancer deaths and 1,958,310 new cases are estimated to be diagnosed in the United States.
The increasing request for blood testing can be attributed to the increasing aging population and the growing size of test ordering profiles. Blood tests allow doctors to diagnose various diseases at a much earlier stage, allowing for improved treatment outcomes. According to new research, Crohn's disease, a type of irritable bowel disease can be diagnosed through blood tests, years before the symptoms start appearing. The early diagnosis of such diseases aids in enhancement of quality of life of patients, improving patient outcomes, and reducing surgery rates.
Future Market Scenario (2024 - 2031F)
Increasing research and development activities by the key players of the market are expected to offer lucrative growth opportunities to the market in the coming years.
After receiving approval from the Food and Drug Administration (FDA), BD MiniDraw, developed by Becton, Dickinson and Company and Babson Diagnostics will be marketed in 2024. The device is a part of the blood collection system that was designed for making routine blood tests less invasive.
Various studies are being conducted that will evaluate the safety and efficacy of autonomous blood drawing devices, for instance, the ongoing Autonomous Blood Drawing Optimization and Performance Testing (ADOPT). The study is expected to conclude in 2025.
Key Players Landscape and Outlook
Key participants in the blood collection devices market are Becton, Dickinson and Company, Terumo Corporation, Nipro Medical Corporation, Thermo Fisher Scientific Inc., and Greiner Bio-One International GmbH. The market expansion is supported by increasing collaborations focusing upon enhancing patient care with the help of integrated and simplified experiences and rising adoption of novel technologies.
In 2023, Tasso, Inc., one of the leading providers of clinical-grade and patient-centric blood collection solutions and Aptar Digital Health, an expert in the Software as a Medical Device (SaMD) announced collaboration for facilitating blood sample collection for various indications including oncology and chronic conditions. Onboarded patients will be monitoring their symptoms and diseases with the help of Aptar Digital Health provided app, upon the requirement of a blood test, Tasso's devices will be used for collecting the samples and sent for analysis.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work